Related Experiment Video
Updated: Aug 24, 2025

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Thromboembolic and bleeding events in ICU patients with COVID-19: A nationwide, observational study
Lene Russell1, Sarah Weihe2, Emilie Kabel Madsen3
1Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Insights
COVID-19 patients in intensive care units (ICUs) frequently experienced thromboembolic and bleeding events. Increased doses of thromboprophylaxis did not appear beneficial for these critically ill patients.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Hematology
Background:
- Coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs) face a heightened risk of thromboembolic complications.
- Understanding the incidence and predictors of these events is crucial for managing critically ill patients.
Purpose of the Study:
- To describe the occurrence of thromboembolic and bleeding events in Danish ICU patients with COVID-19 during the initial pandemic waves.
- To identify factors associated with these events and their impact on 90-day mortality.
Main Methods:
- A sub-study of the Danish Intensive Care Covid database included all SARS-CoV-2 patients admitted to ICUs between March 2020 and June 2021.
- Coagulation variables, thromboembolic/bleeding events, and heparin use were registered. Cox regression analyses assessed associations with mortality.
Main Results:
- Of 1369 patients, 12% experienced thromboembolic events and 23% had bleeding events (6% major bleeding).
- Mechanical ventilation and elevated D-dimer predicted thrombosis; low platelets and hematological malignancy predicted bleeding.
- While 76% received increased thromboprophylaxis, thromboembolic events were not linked to mortality, but bleeding events were (HR 1.55).
Conclusions:
- Thromboembolic and bleeding complications are common in critically ill COVID-19 patients.
- The data suggest that increased doses of thromboprophylaxis may not confer significant benefits in this population.
Background:
Intensive care unit (ICU) patients with Coronavirus disease 2019 (COVID-19) have an increased risk of thromboembolic complications. We describe the occurrence of thromboembolic and bleeding events in all ICU patients with COVID-19 in Denmark during the first and second waves of the pandemic.
Methods:
This was a sub-study of the Danish Intensive Care Covid database, in which all patients with SARS-CoV-2 admitted to Danish ICUs from 10th March 2020 to 30th June 2021 were included. We registered coagulation variables at admission, and all thromboembolic and bleeding events, and the use of heparins during ICU stay. Variables associated with thrombosis and bleeding and any association with 90-day mortality were estimated using Cox regression analyses.
Results:
We included 1369 patients in this sub-study; 158 (12%, 95% confidence interval 10-13) had a thromboembolic event in ICU and 309 (23%, 20-25) had a bleeding event, among whom 81 patients (6%, 4.8-7.3) had major bleeding. We found that mechanical ventilation and increased D-dimer were associated with thrombosis and mechanical ventilation, low platelet count and presence of haematological malignancy were associated with bleeding. Most patients (76%) received increased doses of thromboprophylaxis during their ICU stay. Thromboembolic events were not associated with mortality in adjusted analysis (hazard ratio 1.35 [0.91-2.01, p = .14], whereas bleeding events were 1.55 [1.18-2.05, p = .002]).
Conclusions:
Both thromboembolic and bleeding events frequently occurred in ICU patients with COVID-19. Based on these data, it is not apparent that increased doses of thromboprophylaxis were beneficial.
More Related Videos
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction
Pulmonary Embolism III: Nursing Management

